🇺🇸 Continuous Infusion of ropivacaine in United States

Continuous Infusion of ropivacaine (Continuous Infusion of ropivacaine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Continuous Infusion of ropivacaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Continuous Infusion of ropivacaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Continuous Infusion of ropivacaine in United States?

Henry Ford Health System is the originator. The local marketing authorisation holder may differ — check the official source linked above.